The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds.

Makoni, Pedzisai A; Ranchhod, Janeeta; WaKasongo, Kasongo; Khamanga, Sandile M; Walker, Roderick B

Makoni, Pedzisai A; Ranchhod, Janeeta; WaKasongo, Kasongo; Khamanga, Sandile M; Walker, Roderick B.

Afiliação

Makoni PA; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
Ranchhod J; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
WaKasongo K; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
Khamanga SM; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
Walker RB; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.

Saudi Pharm J ; 28(3): 308-315, 2020 Mar.

Article em En | MEDLINE | ID: mdl-32194332

Palavras-chave

Clarithromycin; Didanosine; Efavirenz; Hansen solubility parameter; Lipid nanoparticles and nanocarriers; Minocycline hydrochloride; Mometasone furoate; Solubility

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: África do Sul

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google